Page 7 - Mankind Pharma

Mankind Pharma acquires stake in Upakarma Ayurveda for undisclosed sum

Mankind Pharma on Monday said it has acquired a majority stake in Upakarma Ayurveda, engaged in developing, manufacturing and selling ayurvedic and herbal products for an undisclosed amount. The company's decision to invest will empower Upakarma Ayurveda to develop a wider range of products and offerings, the drug firm said in a statement. "The current lifestyle has become strenuous where people find it difficult to focus on their health. To fulfil their requirements, consumers are considering Ayurvedic remedies for long-term sustenance and boosting immunity over time. "As Mankind Pharma works towards improving the healthcare of people, we have associated with Upakarma Ayurveda in order to cater to the emerging needs of consumers," Mankind Pharma Vice Chairman and Managing Director Rajeev Juneja said. Mankind Pharma acquired the ayurvedic soulutions firm through one of its subsidiaries. Upakarma Ayurveda Founder & Managing Director Vishal Kaushik said that with the partnership, ..

Expensive deal valuations to hit Torrent Pharma's near-term earnings

Sales trajectory in domestic formulations and resolution of regulatory issues are other triggers

Mankind Pharma files for IPO, could be second largest among pharma firms

The offer for sale is expected to be anywhere between Rs 5000-5500 crore, say sources

Mankind Pharma forays into agri-tech space, plans to invest Rs 200 crore

Mankind Pharma on Monday announced its foray into the agri-tech segment, with plans to invest up to Rs 200 crore in the first two to three years

From Coca-Cola to Apple Inc, here are India's best unlisted companies

In all, 18 out of the best 30 unlisted companies in the 2021 league table are local subsidiaries of global multinationals.

Stocks to Watch: DRL, Mankind, Sun Pharma, Wipro, Kalpataru, TTML, Airlines

Ambuja Cement, Nestle India and Veritas to announce December quarter results today.

Mankind Pharma acquires two derma and respiratory brands from Dr Reddy's

Mankind Pharma to take over manufacturing, marketing and distribution of both products in India; entire integration and transition of the brands likely to be completed by March

Mankind Pharma signs agreement to buy Panacea Biotec Pharma's domestic biz

Panacea Biotec Pharma is a subsidiary of vaccine maker Panacea Biotec; its domestic biz had a turnover of Rs 219 cr in FY21; Adar Poonawalla holds 8.6% stake in the firm

Covid-19 & low base in 2020 boost anti-infectives growth, shows data

Antibiotics, antivirals spur drug category; chronic therapies post lower numbers

Mankind, BDR Pharma join hands to launch anti Covid-19 pill Molulife

Mankind Pharma on Wednesday said it has joined hands with BDR Pharmaceuticals to launch oral anti COVID-19 pill Molulife (Molnupiravir) in the country. The tie-up is a licensing arrangement where production is by BDR Pharma and marketing, selling, promotion, distribution is by Mankind Pharma, the company said in a statement. On Tuesday, the Drugs Controller General of India (DCGI) granted permission for restricted use of antiviral medication Molnupiravir under emergency situation for treatment of COVID-19 in adult patients who have a high risk of progression of the disease. This launch further enhances the COVID-19 treatment portfolio in BDR's product basket with the addition of generic Molnupiravir. We are pleased to collaborate with Mankind Pharma to take one step forward in fighting the virus," BDR Pharma Director Business Development Raheel Shah stated. Mankind Pharma Senior President (Sales & Marketing) Sanjay Koul noted that a pill for COVID-19 is bound to go miles in ...

Mankind Pharma inks distribution pact with BDR Pharma for Covid drug

Delhi-based Mankind Pharma operates in 34 overseas destinations.

Mankind Pharma eyes 50% revenue from chronic therapy drugs in 3 years

With the launch, the company has become the first Indian and second global firm to develop the drug, which is a generic version of Abbott's Duphaston

Mankind Pharma may partner RDIF for Russian Covid-19 vaccine Sputnik V

According to sources close to the development, talks are in advanced stages between Mankind Pharma and RDIF

Domestic drug market growth slows top 4.5% in January, some therapies drag

Respiratory segment and anti-infectives contract; Cardiac, anti-diabetic growth rates plummet

Mankind Pharma partners with South Korea's Daewoong for Covid drug

Will conduct clincial trials on anti-parasitic drug they claim is more effective than remdesivir

Mankind Pharma eyes acquisition of biotech firms, plans new launches

Mankind became the first Indian and second global company to develop a dydrogesterone containing drug for treatment of pregnancy-related complications

Mankind Pharma looking to achieve $1-bn turnover by 2021: Official

It has recently ventured into the US market with the filing of 12-15 ANDAs every year

Mankind Pharma set to foray into diagnostics with Pathkind

The company's initial focus will be Uttar Pradesh followed by Uttarakhand, Bihar, and North-East